Sponsor or institution
Clinical trials and research at Erasca, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Erasca, Inc. that are recruiting, at sites in 3 countries (most in United States (2), Canada (1), South Korea (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
ERAS-4001 for advanced or metastatic solid tumors with KRAS mutations.
This trial will try the oral drug ERAS-4001, alone or with other cancer therapies, in adults with advanced or metastatic solid tumors that have specific KRAS mutations.
-
Testing ERAS-0015 in patients with advanced solid tumors
This study is testing a new drug called ERAS-0015 to see if it is safe and effective for people with advanced solid tumors that have certain RAS mutations.
Quick answers
How many clinical trials run by Erasca, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Canada (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.